Bioimpedance and brain natriuretic peptide in peritoneal dialysis patients

Contributions to Nephrology

Volumn 178, Issue , 2012, Pages 174-181

  Crepaldi, Carlo ^a   Lamas, Elena Iglesias ^a   Martino, Francesca Katiana ^a   Rodighiero, Maria Pia ^a   Scalzotto, Elisa ^a   Wojewodzka Zelezniakowicz, Marzena ^a   Rosner, Mitchell H ^b   Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862123401     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000337849     Document Type: Article

References (32)

1. Krediet RT, Smit W, Coester AM, et al: Dry body weight and ultrafiltration targets in peritoneal dialysis. Contrib Nephrol. Basel, Karger, 2009, vol 163, pp 90- 95.
2. Van Biesen W, Williams JD, Covic AD, et al: Fluid status in peritoneal dialysis patients: The European Body Composition Monitoring (EuroBCM) Study Cohort. PLoS One 2011;6:e17148.
3. Kotanko P, Levin NW, Zhu F: Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant 2008;23:808- 812.
4. Piccoli A, Pastori G, Guizzo M, et al: Equivalence of information from single versus multiple frequency bioimpedance vector analysis in hemodialysis. Kidney Int 2005;67:301- 313.
5. Tan BK, Chan C, Davies SJ: Achieving euvolemia in peritoneal dialysis patients: a surprisingly difficult proposition. Semin Dial 2010;23:456- 461.
6. Haapio M, Honkanen E, Ronco C: Brain natriuretic peptide in peritoneal dialysis patients. Contrib Nephrol. Basel, Karger, 2009, vol 163, pp 110- 116.
7. Konings C, Kooman JP, Schonck M, et al: Fluid status, blood pressure and cardiovascular abnormalities in PD patients. Perit Dial Int 2002;22: 477- 487.
8. Enia G, Mallamaci F, Benedetto FA, et al: Long- term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001;16:1459- 1464.
9. Vonesh E, Moran J: Mortality in end- stage renal disease. A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999;10:354- 365.
10. Velasquez MT, Lew SQ, Von Albertini B, et al: Control of hypertension is better during hemodialysis than during continuous ambulatory dialysis in ESRD patients. Clin Nephrol 1997;48: 341- 345.
11. Cocchi R, Degli Esposti E, Fabbri A, et al: Prevalence of Hypertension inpatients on peritoneal dialisi: results of an Italian multicnete study. Nephrol Dial Transplant 1999;14:1536- 1540.
12. Johnson DW, Dent H, Hawley CM, et al: Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol 2009;4:1620- 1628.
13. Krediet RT: Dry Body weight: water and sodium removal targets in PD. Contrib Nephrol. Basel, Karger, 2006, vol 150, pp 104- 110.
14. Silva AM, Heymsfield SB, Gallagher D, et al: Evaluation of betweenmethods agreement of extracellular water measurements in adults and children. Am J Clin Nutr 2008;88:315- 323.
15. Zhu F, Wystrychowski G, Kitzler T, et al: Application of bioimpedance techniques to peritoneal dialysis. Contrib Nephrol. Basel, Karger, 2006, vol 150, pp 119- 128.
16. Lindley E, Devine Y, Hall L: A wardbased procedure for assessment of fluid status in peritoneal dialysis using bioimpedance spectroscopy. Perit Dial Int 2005;25(S3):S46- S48.
17. Lopot F, Nejedly B, Novotna H, et al: Age- related extracellular to total body water volume ratio (ECV/TBW) - can it be used for 'dry weight' determination in dialysis patients? Application of multifrequency bioimpedance measurement. Int J Artif Organs 2002;25:762- 769.
18. Chamney PW, Wabel P, Moissl UM: A whole- body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007;85:80- 89.
19. Wang J, Pierson R: Disparate hydration of adipose and lean tissue requires a new model for body water distribution in man. J Nutr 1976;106:6.
20. Woodard GE, Rosado JA: Recent advances in natriuretic peptide research. J Cell Mol Med 2007;11:1263- 1271.
21. Crimmins DL, Kao JL: A glycosylated form of the human cardiac hormone pro B- type natriuretic peptide is an intrinsically unstructured monomeric protein. Arch Biochem Biophys 2008;475:36- 41.
22. Weber M, Hamm C: Role of B- type natriuretic peptide (BNP) and NTPROBNP in clinical routine. Heart 2006;92:843- 849.
23. Lee JA, Kim DH, Yoo SJ, et al: Association between serum N- terminal pro- brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006;26:360- 365.
24. Akiba T, Tachibana K, Togashi K, et al: Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995;44(suppl 1):S61- S64.
25. Bavbek N, Akay H, Altay M, et al: Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Perit Dial Int 2007;27:663- 668.
26. Sav T, Inanc MT, Dogan A, et al: Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients. Nephrology 2010;15:307- 312.
27. Papakrivopoulou E, Lillywhite S, Davenport A: Is N- terminal probrain- type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients? Nephrol Dial Transplant 2012;27:396- 401.
28. Paniagua R, Amato D, Mujais S, et al: Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX Trial. Clin J Am Soc Nephrol 2008;3:407- 415.
29. McCormick BB, Bargman JM: The implications of the ADEMEX study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal. Curr Opin Nephrol Hypertens 2003;12:581- 585.
30. Valle R, Aspromonte N, Milani L, et al: Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 2011;16:519- 529.
31. Tuy T, Peacock F: Noninvasive volume assessment in the emergency department: a look at B- type natriuretic peptide and bioimpedance vector analysis. Contrib Nephrol. Basel, Karger, 2011, vol 171, pp 187- 193.
32. Tanino Y, Shite J, Paredes OL: Whole body bioimpedance monitoring for outpatient chronic heart failure follow up. Circ J 2009;73:1074- 1079.